First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses - Concepedia

Concepedia

Publication | Open Access

First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses

DOI Full Paper Access

115

Citations

20

References

2014

Year

Max Karner, Andreas Kocjan, Stefan Schreiber, Georg von Boyen, Peter Uebel, Carsten Schmidt, Limas Kupčinskas, Ion Dina, Frank Zuelch, G. Keilhauer,

The American Journal of Gastroenterology

Abstract

The primary end point analysis showed a statistically significant improvement in disease activity during LT-02 treatment in comparison with placebo. The drug was found to be very safe.

References

	Year	Citations

Page 1